Feb 9, 2017 Syros Announces Publication in Cell Highlighting Gene Control as Important and Rapidly Progressing Area of Research for Yielding New Medicines to Treat Cancer
Dec 10, 2016 Syros Pharmaceuticals Presents New Preclinical Data Demonstrating Significant Anti-Proliferative Effects of its First-in-Class Selective RARĪ± Agonist in Genomically Defined Subsets of Breast Cancer
Dec 5, 2016 Syros Pharmaceuticals Presents Data at ASH Annual Meeting Further Supporting Clinical Potential of Its First-in-Class Selective RARĪ± Agonist for Genomically Defined Subsets of AML and MDS Patients
Nov 21, 2016 Syros Pharmaceuticals Announces Late-Breaking Presentation on SY-1425 at San Antonio Breast Cancer Symposium
Nov 14, 2016 Syros Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
